Jie Jack Li is the CSO of GenHouse Bio. Previously, he was VP of Discovery Chemistry at ChemPartner, an Associate Professor of Chemistry at the University of San Francisco, and a Medicinal Chemist at Pfizer and Bristol-Myers Squibb. He has authored or edited over 30 books, including Blockbuster Drugs (Oxford University Press, 2014), which won the 2015 Alpha Sigma Nu Science Book Award.
After summarising current vaccine research and the hunt for a universal vaccine, Li provides an overview of an tiviral influenza treatments from M2 ion channel inhibitors to neuraminidase inhibitors such as Tamiflu. * Claas Kirchhelle, Metascience *